Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

38.53
-0.7200-1.83%
Post-market: 38.900.3700+0.96%19:53 EDT
Volume:4.82M
Turnover:187.09M
Market Cap:44.89B
PE:64.22
High:39.52
Open:39.02
Low:38.32
Close:39.25
52wk High:39.52
52wk Low:18.21
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.08
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.79
PE(LYR):31.84

Loading ...

Feb 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 27, 2021

Major Issues Report

8-K - Current report
Oct 27, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 27, 2021

Major Issues Report

8-K - Current report
Jul 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report
Jul 21, 2021

Major Issues Report

8-K - Current report
Jul 06, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Major Issues Report

8-K - Current report